Another graduate from St. Andrews School of Medicine is set to virtually “cross the stage” this Friday. Quenton Hurst, is the newest graduate with a master’s in molecular medicine. Following a year navigating the dynamics of online learning in the time of COVID-19, he is ready to take the next steps post-graduation.
Beginning his journey at St. Andrews in 2019, Quenton embarked on a master’s in molecular medicine researching cardiomyocyte proarrhythmicity in acute hyperglycaemic conditions. Originally from Rockport, Massachusetts, his decision to come to Scotland was made after receiving the St. Andrews’s Society of the State of New York Scholarship to study for a year at a Scottish university of his choice. Choosing St. Andrews was made easy due to the quality of teaching and access to cutting edge research in cardiac studies.
Currently, you can find Quenton in what is termed the “bat cave” in the Pitt lab doing research on potential anti-viral inhibitors to fight COVID-19 – an 18-month project that is being funded through the UKRI BBSRC. Quenton hopes to first pursue a PhD here in St. Andrews and then bring his knowledge back to the U.S. where he hopes to pursue a medical degree to eventually become a practicing clinician in the area of cardiac electrophysiology.
When asked what he’ll miss most about St. Andrews, Quenton noted the community feeling of St. Andrews and the collaborative nature he felt from fellow classmates, colleagues, and lecturers. Quenton also mused on the stunning backdrop of St. Andrews, poignantly reflecting on how he was working on cutting edge research amidst historic landscapes – giving him the best of both the new and old world.